Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FVIT-BX
- Development stage
- Unknown
- Lead developer
- Favnox Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Intramuscular, Intravenous
01
Overview
**FVIT-BX** is a prescription parenteral vitamin B-complex formulation marketed by Favnox Pharmaceuticals for correction of vitamin B deficiencies and supportive nutritional care. It is supplied as an injectable preparation for intramuscular or intravenous use and contains methylcobalamin, thiamine hydrochloride, pyridoxine hydrochloride, and dexpanthenol. These vitamins function as essential cofactors in pathways supporting cellular energy metabolism, neurologic function, hematopoiesis, and carbohydrate, lipid, and amino-acid metabolism.
- Brand names
- FVIT-BX
02
Targets
CYP3A4 (Cytochrome P450 3A4)XO (Xanthine Oxidoreductase)
Beyond the preview
Go deeper on FVIT-BX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FVIT-BX.